Filing Details

Accession Number:
0001593968-21-002151
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-09-17 20:59:21
Reporting Period:
2021-01-26
Accepted Time:
2021-09-17 20:59:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
738214 Aemetis Inc AMTX Industrial Organic Chemicals (2860) 261407544
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1236181 P Francis Barton 20400 Stevens Crek Blvd, Suite 700
Cupertino CA 95014
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-02-16 10,000 $9.00 13,452 No 4 S Direct
Common Stock Disposition 2021-02-16 10,000 $9.00 13,452 No 4 S Direct
Common Stock Disposition 2021-02-25 20,000 $10.00 13,452 No 4 S Direct
Common Stock Disposition 2021-03-01 20,000 $12.00 13,452 No 4 S Direct
Common Stock Disposition 2021-03-02 10,000 $15.00 13,452 No 4 S Direct
Common Stock Disposition 2021-03-12 20,000 $20.00 13,452 No 4 S Direct
Common Stock Disposition 2021-01-26 20,000 $9.10 13,452 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. 1.These transactions were incorrectly reported in Table II on prior Form 4s filed by the Reporting Person in connection with the Reporting Persons exercise of stock options and sale of common stock from those issuances.
  2. The Reporting person sold the 10000 shares acquired on sale date through by paying cash for the option cost of the 1/18/2018 grant.
  3. The Reporting person sold the 10000 shares acquired on sale date through by paying cash for the option cost of the 11/16/2017 grant.
  4. The Reporting person sold the 10000 shares acquired on sale date through by paying cash for the option cost of the 1/8/2019 grant.
  5. The Reporting person sold the 10000 shares acquired in 2015 through RSA issuances by the Company and 10000 acquired on sale date through by paying cash for the option cost of the grant 11/16/2017.
  6. As of the date of the first reported transaction on this Form 4, the Reporting Person beneficially owned 23,452 shares of the Issuers common stock. Each of the sale and withholding transactions reported herein was with respect to shares received from the exercise of stock options previously described on prior Form 4s except for 10,000 on 1/26/2021 sale.